GlaxoSmithkline Consumer Healthcare is subsidiary of GlaxoSmithKline plc of UK, a global science based healthcare company. GlaxoSmithkline Consumer Healthcare's core business is manufacturing of health dirnks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more
GlaxoSmithKline Consumer Healthcare (GSK Consumer Healthcare) is reportedly planning to set up a large manufacturing facility close to the east coast in southern Andhra Pradesh. In this regard, the company has shortisted one location each in Nellore and Chittoor for the plant, which will produce Horlicks and Boost branded products with an investment of up to Rs 1,000 crore.
Further, GSK is scouting for about 100 acres of land at the two locations, apart from connectivity to the natural gas grid, and has conveyed plans to produce Foodles, which is its instant noodles product, biscuits and oats under the Horlicks brand, apart from health food drinks.
The promoters holding in the company stood at 72.46% while Institutions and Non-Institution held 12.78% and 14.77% respectively.
The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 4992.80 on 29/5/2014 and a 52 week low of Rs 3875.00 on 28/7/2013.
Current price of stocks is Rs 4970.05, up by 30.60 points from its previous closing of Rs 4939.45 on the BSE.
No comments:
Post a Comment